IBL HealthCare Limited has released its quarterly financial report for the period ended September 30, 2026, highlighting a slight increase in revenue but a decrease in net profit compared to the previous year.
- Revenue for the quarter was PKR 1,121.19M, up from PKR 1,120.92M in the same period last year.
- Gross profit decreased to PKR 391.85M (35% margin) from PKR 400.09M (36% margin) due to inventory liquidation.
- Profit after taxation fell to PKR 64.05M from PKR 69.69M year-on-year.
- Finance costs significantly decreased by 82% to PKR 1.0M, benefiting from lower policy rates.
- Current liabilities decreased to PKR 1,164.16M from PKR 1,474.64M, indicating improved cash management.
- Cash and cash equivalents at the end of the period stood at PKR 441.54M, down from PKR 727.18M.
- The report is un-audited and reflects the company's ongoing strategic investments despite a challenging macroeconomic environment.